{"entity":{"type":"insider","cik":"0001651308","url":"/insider/0001651308","json_url":"/insider/0001651308.json","name":"BeiGene, Ltd.","name_source":"as-filed","also_issuer":true,"cross_url":"/issuer/0001651308"},"coverage_statement":{"n_transactions":1,"n_filings":1,"first":"2021-09-28","last":"2021-09-28","span_basis":"filed_date"},"name_variants":[{"name":"BeiGene, Ltd.","source":"filing","n_filings":1,"first_seen":"2021-09-28","last_seen":"2021-09-28"}],"transactions":[{"id":4578926,"accession":"0001651308-21-000197","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001651308-21-000197","line_url":"/filing/0001651308-21-000197#line-1","is_derivative":false,"issuer_cik":"0001509745","issuer_name":"LEAP THERAPEUTICS, INC.","issuer_ticker":"LPTX","issuer_name_source":null,"issuer_url":"/issuer/0001509745","owner_cik":"0001651308","owner_name":"BeiGene, Ltd.","owner_display_name":"BeiGene, Ltd.","owner_url":"/insider/0001651308","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2543800.0,"shares_display":"2,543,800","price_per_share":2.85,"price_display":"2.85","price_state":"stated","total_value":7249830.0,"total_display":"7,249,830.00","total_whole":"7,249,830","shares_owned_after":7348437.0,"shares_owned_after_display":"7,348,437","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-09-24","filed_date":"2021-09-28","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":1,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":1,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":1},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001509745","name":"LEAP THERAPEUTICS, INC.","url":"/issuer/0001509745","role":"Ten percent owner","n_filings":1,"first_seen":"2021-09-28","last_seen":"2021-09-28"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001651308","retrieved_at":"2026-08-23T12:42:55+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}